London midday: Pharma deals lift stocks as FTSE 100 nears 6,700
22nd Apr 2014 11:36
- FTSE 100 at highest since April 4th - Astra jumps on Pfizer takeover speculation - GSK announces massive three-part deal with Novartis techMARK 2,741.04 +2.28% FTSE 100 6,691.88 +1.01% FTSE 250 16,103.19 +1.23% Heightened M&A activity in the pharmaceutical sector gave UK markets a boost on Tues
Read moreFTSE 250 movers: Hikma drops after UBS reduces rating
8th Apr 2014 15:32
Similarly, pharmaceuticals group Hikma led the fallers after UBS cut its rating on the stock from 'buy' to 'neutral' on valuation grounds, saying that it is 'time to take a pause and breathe' after the stock's recent performance. Chemicals business Synthomer also sunk after JPMorgan Cazenove downgr
Read moreBroker tips: UK grocers, Whitbread, Synthomer...
8th Apr 2014 12:23
The outlook for profits across the UK grocery sector is 'highly constrained', according to Shore Capital, which has raised concerns about rising pricing contagion. The broker retained its 'sell' ratings for supermarket rivals Tesco and WM Morrison and online grocer Ocado. "We have harboured growing
Read moreLondon midday: Stocks at two-week low as Sports Direct and grocers fall
8th Apr 2014 11:52
- FTSE 100 at lowest since March 24th - Ukraine tensions flare up - US stocks fall ahead of Q1 earnings season - Sports Direct sinks on Ashley share sale, grocers fall techMARK 2,697.79 -1.18% FTSE 100 6,559.14 -0.96% FTSE 250 16,015.95 -1.52% UK stocks fell one per cent by Tuesday lunchtime, tra
Read moreHikma 'fairly valued' after recent run, UBS downgrades
8th Apr 2014 09:28
UBS has lowered its recommendation for pharmaceuticals group Hikma from 'buy' to 'neutral' on valuation grounds, saying that it is 'time to take a pause and breathe' after the stock's recent performance. "As the stock trades near our price target [1,700p] and as we see no reason in the short-term t
Read moreTuesday broker round-up UPDATE
8th Apr 2014 09:18
API Group: Numis lowers target price from 90p to 84p, while upgrading from add to buy. Cranswick: Investec increases target price from 1315p to 1390p retaining its buy recommendation. Daisy Group: FinnCap moves target price from 175p to 185p and retains a hold recommendation. DP World: Nomura rai
Read moreWednesday broker round-up UPDATE
2nd Apr 2014 08:48
Aberdeen Asset Management: Canaccord Genuity reduces target price from 540p to 460p, while its buy recommendation is kept. Anglo American: JP Morgan ups target price from 1260p to 1300p, while leaving its underweight rating unchanged. Aviva: JP Morgan raises target price from 528p to 570p maintain
Read moreHikma given US regulatory clearance for Eatontown facility
2nd Apr 2014 07:57
Jordanian drug group Hikma Pharmaceuticals has been told by the US regulator that its Eatontown oral products facility in New Jersey has passed inspection. Hikma has spent $45m in remediation on Eatontown after receiving a warning letter from the US Food and Drug Administration (FDA). A letter fro
Read moreFTSE 250 movers: Crest Nicholson hit by reports of major shareholder sale
21st Mar 2014 14:00
Crest Nicholson dropped after Bloomberg reported that the housebuilder's largest publicly disclosed shareholder, Deutsche Bank, is disposing of as many as 16.5m shares. The German bank is thought to have a 10 per cent stake in the company. Pharmaceuticals firm Hikma was also trading in the red toda
Read moreJefferies downgrades Hikma on limited upside
21st Mar 2014 12:14
Jefferies has lowered its recommendation for Hikma Pharmaceuticals from 'buy' to 'hold' and slashed its target price from 1,500p to 1,250p, saying that upside for the stock is now limited after its recent strong run. "We continue to view Hikma as a quality business but re-evaluate the stock after a
Read moreLondon midday: Stocks set for weekly gain as miners rise
21st Mar 2014 11:45
- Miners recover after recent slump - Obama imposes more sanctions on Russia - Markets await speeches from Fed officials - Burberry, RBS, Hikma hit by broker downgrades techMARK 2,807.91 +0.27% FTSE 100 6,564.71 +0.34% FTSE 250 16,228.56 +0.07% UK equities were trading higher on Friday with the FT
Read moreFriday broker round-up UPDATE
21st Mar 2014 09:36
Anglo American: Nomura reduces target price from 1550p to 1475p and retains a neutral rating. Antofagasta: Nomura cuts target price from 800p to 720p and stays with its reduce rating. Canaccord Genuity reduces target price from 1030p to 880p, while its buy recommendation is kept. ASOS: UBS reduces
Read moreLondon open: Mining stocks provide a lift early on
21st Mar 2014 08:27
- Miners recover after recent slump - Obama imposes more sanctions on Russia - Markets await speeches from Fed officials techMARK 2,803.23 +0.11% FTSE 100 6,565.89 +0.36% FTSE 250 16,219.13 +0.01% UK equities opened slightly higher on Friday as decent gains in the mining sector lifted the resource
Read moreTuesday broker round-up UPDATE
18th Mar 2014 08:58
Antofagasta: Investec places its target price (prev.: 753p) under review, while leaving its sell recommendation unchanged. Ashtead Group: Credit Suisse raises target price from 1000p to 1100p and stays with its outperform rating. UBS increases target price from 875p to 1020p retaining its buy recom
Read moreMonday broker round-up UPDATE
17th Mar 2014 08:31
Admiral Group: Credit Suisse raises target price from 1340p to 1425p and keeps a neutral rating. African Barrick Gold: Canaccord Genuity ups target price from 315p to 330p and maintains a buy recommendation. Amara Mining: Canaccord Genuity moves target price from 25p to 33p and reiterates its buy
Read more